USRX Price: Buy USRX Crypto, United States RX

USRX crypto, also marketed as United States RX, is one of the more aggressively promoted memecoins to land on Solana in 2026. Its TikTok and X feeds claim it is "Trump's Healthcare Crypto," promise 80 to 90 percent prescription savings, and reference an endorsement from World Liberty Financial. None of those claims have been verified by the Trump administration, the actual TrumpRx.gov program, or World Liberty Financial. The on-chain reality is starker still: the main Solana USRX token is down roughly 99.9 percent from its February all-time high, has about $11,000 of market cap as of April 30, 2026, and shares its ticker with at least a dozen unrelated contracts on Base and Solana.

This guide covers what the USRX coin actually is, what its promoters claim it is, what the data shows, where it trades, and the red flags any buyer should know before sending a single dollar to one of these tokens. We will look at live charts, the current market, market capitalization, USRX use cases, the realistic place of meme coins in a portfolio, and what financial advice would actually look like for an asset like this. Every number cited has a date and a source. None of this is investment advice.

What is USRX (United States RX) crypto?

USRX crypto, which trades under the longer name "United States RX," is a token that launched on Solana on February 10, 2026. The most-cited contract, the one Phantom and CryptoRank treat as the headline asset, is `USRX8A1BNVzPSWt9tXA1ZjeMWWnpsWktdhueCBDZAjS`. Total supply is 999,999,995, fully circulating, with roughly 2,036 holders on Phantom as of late April 2026.

Its self-description, pulled directly from the Phantom token page, is "Powering the next-generation of US Health Care." Promoters extend that into a broader pitch: USRX, they say, will use blockchain to slash drug prices and connect Americans to manufacturers without insurance middlemen. That is the surface story.

The deeper story is fragmentation. As we will see in a later section, "USRX" is not one token. It is a name shared by at least three Solana contracts and ten Base contracts, all unrelated to one another. None of them have a published team, an audit, a whitepaper, or any verified institutional connection.

The Trump healthcare claim about USRX, debunked

The most important thing to understand about USRX crypto is that the political-affiliation claims are not real. Multiple analyst outlets, including CoinCodex, 99bitcoins, BTCC and Bitrue, have published the same conclusion in slightly different words: "There is no verifiable link to the Trump administration, TrumpRx, World Liberty Financial or any U.S. government program."

Here is what is true.

• TrumpRx.gov is real. It launched on February 5, 2026, as a federal portal where consumers can buy a list of about 43 specific drugs directly from manufacturers, including Ozempic, Wegovy and AstraZeneca and EMD Serono products, at discounted prices that bypass insurance. The program was first announced on September 30, 2025 with the Pfizer CEO in the Oval Office.
• TrumpRx has no token. The White House Fact Sheet describing TrumpRx contains zero references to crypto, blockchain, or any tokenized payment rail. Purchases are dollar-denominated and direct from drug makers.
• The White House crypto page does not mention USRX. Neither does any official government source. The Working Group statement on digital assets covers blockchain at a high level and is unrelated to any specific memecoin.
• World Liberty Financial has not endorsed USRX. WLF is the Trump-family-affiliated DeFi project, and it has its own tokens. USRX is not among them.

USRX launched five days after TrumpRx.gov went live. The timing is the entire connection. Promoters borrowed a name, wrapped a Solana token around it, and pushed the narrative on social media. CoinCodex's verdict is the cleanest summary: "almost certainly a rug-pull scam, or at best a low-effort meme coin capitalizing on political sentiment."

USRX price today, history and trend

The USRX price today, on the primary Solana contract, is around $0.00001056 per CryptoRank as of April 30, 2026, with USRX currently trading well below a tenth of a cent. That is a drawdown of approximately 99.9 percent from the all-time high of $0.00749 on February 12, 2026, just two days after the token launched. The price history of USRX, in other words, fits a clear bearish price trend that has not yet reversed.

The price history follows the canonical political-memecoin pattern, the same one OFFICIAL TRUMP and MELANIA traced before it. A vertical pump in the first 48 hours, an 80 percent drawdown in the first week, then a long bleed for two and a half months as launch buyers exit and there is no organic demand to replace them. The trading volume across the last 24 hours has shrunk to a few dollars on the primary Solana contract, which is a clear sign of a thin, post-pump market.

The trend now is sideways at the floor. With $4 of daily volume on Phantom and a market cap of about $11,000, the token is effectively dormant. The price USD chart has flattened out near the all-time low, and new movement would require either a fresh promotional push or an exit by one of the larger holders, and neither would be welcome news to current holders. Spot trading at this level is a coin-flip dressed up as a market.

USRX coin tokenomics and total supply

There is no published USRX tokenomics breakdown for any of the contracts. The Bitget Web3 Academy entry on the project explicitly notes that "tokenomics transparency remains limited" and labels the team "publicly undisclosed." That is unusual for a token claiming to be a drug-pricing oracle for the United States.

Here is what is observable for the primary Solana contract.

A round 1 billion supply, full circulation from day one, no publicly locked liquidity and no team identity is not the structure of an infrastructure project. It is the standard launch profile for opportunistic Solana memecoins riding a news narrative. Real healthcare-facing projects, when they have launched on chain, publish tokenomics, lock liquidity for years, name their advisors and submit to audits. There is no staking program for USRX, so anyone framing it as a yield asset is wrong: there are no staking rewards, no validator role and no ability to stake the token for passive income. You either hold it and hope, or you sell it.

USRX coin variants: many listed coins, one ticker

This is where USRX crypto differs from a standard scam. It is not one token to avoid. It is a swarm.

Plus six more Base contracts that Coinbase has indexed as USRX-named tokens. Coinbase auto-creates a price page for any Base ERC-20 traded through its DEX router, which is why there are so many "USRX" pages on Coinbase.com that are not actual listings.

The practical takeaway: when you search "USRX" on a search engine, you are almost certainly going to see results for several different tokens, all unrelated, all minted by different anonymous wallets. Even an experienced trader can buy the wrong contract. A first-time crypto buyer almost certainly will. That alone is grounds to walk away.

How to buy USRX: from Phantom to Bitget

If, despite all of the above, you intend to buy USRX crypto, the realistic paths are narrow.

For the primary Solana USRX, the realistic flow is:

1. Hold SOL in a Solana wallet (Phantom, Solflare, or Backpack are the standard options).

2. Open Jupiter and paste the exact contract address `USRX8A1BNVzPSWt9tXA1ZjeMWWnpsWktdhueCBDZAjS`. Do not search by ticker. Multiple tokens share the name.

3. Set a generous slippage tolerance. With a market cap of $11,000 and daily volume of $4, even small trades cause heavy slippage.

4. Acknowledge Phantom's "unverified token" warning if you proceed.

5. Sign and send.

For the Base variants, the path runs through Uniswap or Coinbase's wallet DEX trade. Coinbase displays USRX price pages but does not offer the token as a centralized spot listing. Bitget likewise has price pages and a Web3 wallet path, not a CEX listing.

There is no Coinbase, Binance, Kraken, OKX, Bybit, or Bitget centralized exchange listing for any USRX contract as of late April 2026. Anyone telling you to "buy or sell USRX on Coinbase" is talking about a DEX trade through the Coinbase crypto wallet interface, not a real listing. Decentralized markets are the only place this token actually trades.

USRX to USD: converter, calculator and market stats

For a quick USRX to USD calculator, any one of the major aggregators will do the math for you with the caveat that quotes vary across sources because liquidity is thin.

CoinCodex has flagged price-source fragmentation as a symptom of the bigger problem: in mid-February 2026, USRX was simultaneously quoted at $0.000349 by some aggregators and $0.00729 by others, an order-of-magnitude gap that no real, liquid asset would tolerate. By late April 2026 the quote has converged near zero across sources because most liquidity has drained.

If you want a clean USRX to USD converter, use CryptoRank's primary-contract page and check the result against DexScreener for the underlying pool. Anything else is a guess. Cryptocurrency prices for USRX vary so much across services because there is barely a market behind any of them, and a trusted platform for crypto data should still be cross-checked against on-chain pool depth before you trade. The current price of USRX is only meaningful when you also know which contract it refers to.

Tokenomics red flags in the USRX cryptocurrency

The risk inventory for USRX is dense. Each item below is independently flagged in published analyst coverage.

• Multiple unrelated contracts under one ticker. This alone is unusual. A retail buyer can land on the wrong token through a search engine and have no easy way to tell.
• No verifiable team. Anonymous, no LinkedIn, no advisor list, no real-name developer.
• No whitepaper. Nothing on the website (where one even exists), nothing on CoinGecko, nothing in any third-party archive.
• No audit. No third-party security review of any contract.
• Phantom unverified-token warning. The wallet's automated review flagged this token before any user trade.
• Tokenomics transparency limited. Bitget Academy's own description, not a critic's framing.
• Price fragmentation across aggregators. Mid-February quotes disagreed by an order of magnitude.
• 99.9% drawdown in 80 days. Standard pump-and-dump curve.
• No CEX listings. Listing teams at major exchanges do basic diligence. None passed USRX through.
• Marketing claims do not match verifiable facts. No White House or TrumpRx connection, no World Liberty Financial endorsement, no pharmacy partner, no PBM, no manufacturer.
• Catastrophic slippage at any meaningful trade size. A $1,000 buy on the Solana primary contract is roughly 9 percent of total market cap.

A clean infrastructure token, by contrast, would publish a single canonical contract, name its team, lock liquidity, revoke mint authority, ship audits, and walk a measured listing path through major exchanges. USRX has done none of that. The project's marketing leans into the language of decentralize-everything reform, but the on-chain footprint is the opposite of decentralized governance, with a single anonymous deployer holding full control. None of the published USRX use cases (drug pricing, prescription savings, manufacturer negotiation) have any verifiable on-chain evidence.

USRX vs Trump-themed cryptocurrencies in 2025-2026

USRX crypto did not appear in a vacuum. It is part of a now-recognizable category: Trump-themed political memecoins that pump at launch and then retrace heavily.

OFFICIAL TRUMP, the only one of these tokens with a verified Trump-family connection, has wiped roughly $2 billion off the wallets of an estimated 813,000 buyers, while the family and its partners earned about $100 million in trading fees and other launch-related revenue, per Fortune. The Senate Permanent Subcommittee on Investigations, led by Sen. Blumenthal, has opened an inquiry into Trump-family crypto activity. The broader crypto market in 2026 has moved on from the political memecoin trade, and the marketcap on every Trump-themed token has compressed materially in line with that shift.

The point: even when a Trump token is real and family-endorsed, retail outcomes have been ugly. USRX is not Trump-endorsed and has none of the structure that would protect a buyer.

USRX price predictions and market details for 2026

You will find USRX crypto price predictions from various aggregators forecasting numbers out to 2030. Treat all of them as marketing copy. None of these forecasts factor in:

• The mutable, anonymous-team nature of the contract.
• The fragmentation across thirteen-plus contracts.
• The 99.9 percent drawdown already in the books.
• The total absence of cash-flowing utility.

A realistic outlook for the primary Solana USRX is the same outlook as for any post-launch memecoin that has bled to under $20K market cap: a slow drift along the floor with occasional small spikes if a promoter pushes the chart, followed by a return to baseline. The market details are what they are: $11,000 of market cap, $4 of daily volume, 2,036 holders. Those are not the conditions that produce sustained price discovery.

If USRX ever published a real team, a real audit, a real partnership, locked liquidity, and revoked authority, the conversation would change. None of those things have happened in the 80 days since launch. A serious investment strategy around USRX therefore reduces to "do not allocate," and any sensible cryptocurrency investments in 2026 should sit far ahead of this kind of risk on the diligence checklist. Your own risk tolerance is the deciding factor, but USRX's investment decisions list is short.

Should you buy USRX crypto in 2026 or skip it?

Honest answer for each likely buyer profile:

• Long-term investor. No. USRX has none of the markers of a real project worth holding.
• Short-term speculator. Probably no. The market cap and daily volume are too small for any meaningful trade to exit cleanly. Slippage will eat any thesis.
• Someone who saw the TikTok promo. No. The political-affiliation claims are unverified and have been published as such by every neutral analyst that has covered the project.
• Someone curious about how a memecoin lifecycle plays out. A small test buy, in size you would set on fire, is the cheapest way to see how Phantom warnings, Jupiter routing, and post-launch liquidity actually behave. Use that knowledge on a different token.
• First-time crypto buyer. Especially no. The first of your crypto assets should not be an $11K micro-cap with a fake political wrapper.

The USRX trading story is a clear case study in how a real news cycle (TrumpRx.gov launching February 5, 2026) gets weaponized by anonymous launchers (USRX deploying February 10, 2026) and pushed through social media into wallets that did not check the contract. Reading this section is your check.

Marco Lucchetti

Marco Lucchetti is a senior content strategist and blockchain analyst at Plisio. With over 7 years of experience in cryptocurrency research, DeFi protocols, and payment technologies, Marco specializes in creating clear, data-driven content for a global crypto audience. His work focuses on transaction tracing, crypto compliance, and the future of blockchain infrastructure.